Skip to main content

Table 5 Locoregional response and relapse characteristics for patients with and without glutamine supplementation

From: Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

Characteristic All Glutamine (+) Glutamine (−) P-value
  (N=104) (N=56) (N=48)  
Locoregional response (N; %)     
Complete 15 (14.4) 8 (14.3) 7 (14.5) 0.79
Partial 34 (32.7) 18 (32.1) 16 (33.4) 0.62
Stable 28 (26.9) 16 (28.6) 12 (25.0) 0.31
Progression 27 (26.0) 14 (25.0) 13 (27.1) 0.43
Relapse pattern (N; %)     
None 19 (18.3) 10 (17.9) 9 (18.8) 0.42
Locoregional 20 (19.2) 10 (17.9) 10 (20.8) 0.59
Distant 46 (44.2) 25 (44.6) 21 (43.7) 0.30
Locoregional + distant 19 (18.3) 11 (19.6) 8 (16.7) 0.24